Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Download All
Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.
George D. Demetri, MD
Program Director
George D. Demetri, MD
Alexander Drilon, MD
Pashtoon Kasi, MD

On-Demand Video Webcast

Watch this interactive, on-demand Webcast led by George D. Demetri, MD, and featuring an expert panel discussing best practices in testing for NTRK fusions in solid tumors, current evidence supporting the use of approved TRK inhibitors, and emerging topics, including TRK inhibitor resistance and second-generation agents.

George D. Demetri, MD
Program Director
Alexander Drilon, MD Pashtoon Kasi, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 21, 2020 Expired: August 20, 2021

Podcast

Listen to George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer audience questions from a series of live CCO Webinars focused on when and how to test for NTRK fusions in solid tumors and best practices in using TRK inhibitors.

George D. Demetri, MD
Program Director
Alexander Drilon, MD Pashtoon Kasi, MD
Released: August 14, 2020

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices in testing for NTRK fusions in solid tumors.

George D. Demetri, MD Released: July 10, 2020

Download this slideset for expert perspectives on current best practices in the use of approved TRK inhibitors for patients with solid tumors.

Pashtoon Kasi, MD Released: July 10, 2020

Download this slideset for expert perspectives on emerging next-generation TRK inhibitors and their potential use in managing resistance to first-generation agents, as well key adverse events with TRK inhibitors and management strategies.

Alexander Drilon, MD Released: July 10, 2020

ClinicalThought

Read my thoughts on how I approach TRK inhibitor therapy, including testing for NTRK fusions and monitoring for adverse events.

Alexander Drilon, MD Released: July 10, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue